Pathologic stage is most prognostic of disease‐free survival in locally advanced rectal cancer patients after preoperative chemoradiation
Hak‐Mien Quah(Memorial Sloan Kettering Cancer Center), Martin R. Weiser(Memorial Sloan Kettering Cancer Center), Mithat Gönen(Memorial Sloan Kettering Cancer Center), Karyn A. Goodman(Icahn School of Medicine at Mount Sinai), Jinru Shia(Memorial Sloan Kettering Cancer Center), Bruce D. Minsky(The University of Texas MD Anderson Cancer Center), Deborah Schrag(Dana-Farber Brigham Cancer Center), W. Douglas Wong(Memorial Sloan Kettering Cancer Center), Joanne F. Chou(Memorial Sloan Kettering Cancer Center), Leonard B. Saltz(Memorial Sloan Kettering Cancer Center)
Cited by 267
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k